LifePoint raises $10 million in placement:
This article was originally published in Clinica
LifePoint, which develops noninvasive drug and alcohol diagnostics, has completed a $10 million private placement. The Ontario, California company will use the proceeds for manufacturing and marketing its Impact rapid test system, which is aimed at the workplace, home healthcare, ambulance markets - which together represent a total market of over $1.6 billion, the company says.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.